openPR Logo
Press release

Mice Model Technologies Market to Reach US$ 3.2 Billion by 2031: TMR Study

Mice Model Technologies

Mice Model Technologies

The latest research study released by Transparency Market Research on "๐Œ๐ข๐œ๐ž ๐Œ๐จ๐๐ž๐ฅ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ โ€ณ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Mice Model Technologies industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data.

Mice Model Technologies market is estimated to attain a valuation of US$ 3.2 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.4% during the forecast period, 2022-2031

๐†๐ž๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84893

High incidence of genetic disorders worldwide has led to significant R&D investment in genetic testing and rise in adoption of the CRISPR technology in the healthcare industry. CRISPR/Cas9 gene editing, an emerging technology, is extensively used to make mutations in all kinds of organisms. There is also an eminent need for accurate and speedy treatment with the rise in cases of various contagious diseases. Such scenarios have led to an increase in focus on NOD SCID gamma mouse (NSG mice), the model of choice for humanized mice, cell biology, cancer xenograft modeling, and infectious disease research. The global mice model technologies market is expected to grow at a substantial pace, owing to R&D in vaccines and drugs to curb the spread of COVID-19. Furthermore, increase in demand for personalized medicines and rise in prevalence of chronic diseases are also expected to drive the global mice model technologies market size.

๐’๐ฎ๐ซ๐ ๐ž ๐ข๐ง ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐ข๐ง ๐๐ข๐จ๐ฆ๐ž๐๐ข๐œ๐š๐ฅ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ญ๐จ ๐ƒ๐ซ๐ข๐ฏ๐ž ๐ƒ๐ž๐ฆ๐š๐ง๐ ๐Ÿ๐จ๐ซ ๐Œ๐ข๐œ๐ž ๐Œ๐จ๐๐ž๐ฅ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ

Investment in biomedical research is considered one of the most important indicators of any country's research landscape. In the last decade, biomedical research expenditure has increased manifold across the globe, with developed countries such as the U.S. and the U.K. dominating the landscape. Majority of these investments are made for R&D of animal models.

The National Institutes of Health (NIH), the largest advocate of biomedical research in the world, had a budget of around US$ 31 Bn in 2019, followed by the Bill & Melinda Gates Foundation (BMGF) and the Wellcome Trust (each with approximately US$ 1.08 Bn; 3.1%). Overall, around 89.6% (approximately US$ 32 Bn) of all the grants awarded for biomedical research were allocated to recipient organizations in the U.S. More than 60% of NIH extramural funding involves animal-related research; most of this is allocated to mice-related studies. Thus, increase in biomedical research funding is expected to drive the global mice model technologies market during the forecast period.

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐›๐ž๐Ÿ๐จ๐ซ๐ž ๐ฉ๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84893

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค ๐จ๐Ÿ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐Œ๐ข๐œ๐ž ๐Œ๐จ๐๐ž๐ฅ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

North America dominated the global mice model technologies market, with more than 40% share in 2021. According to the mice model technologies market research study, rise in research and development activities in CRISPR to provide modified products for prevention and treatment of various chronic and rare diseases, such as sickle cell anemia and Alzheimer's diseases, is expected to fuel the market in North America in the near future.

Asia Pacific is also poised to witness significant growth during the forecast period, owing to the increase in adoption of mice models for R&D in COVID-19 prevention and treatment.

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:

Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, GenOway, Ingenious Targeting Laboratory, Merck KGaA, Ozgene Pty Ltd., Taconic Biosciences, Inc., PolyGene AG, The Jackson Laboratory, Yale School of Medicine, University of North Carolina, University of Nebraska Medical Center, Monash University, UMass Chan Medical School, University of Bonn, Columbia University, and The University of Arizona

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง -

๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ

CRISPR Knockout
CRISPR Knockin
Random Insertions
Large, Targeted Insertions
ES Cell Modification (Homologous Recombination)
Others

๐„๐ง๐-๐ฎ๐ฌ๐ž๐ซ

Pharmaceutical Companies
Biotechnology Companies
Academic and Research Facilities
Contract Research and Manufacturing Organizations

๐‡๐š๐ฏ๐ž ๐€๐ง๐ฒ ๐๐ฎ๐ž๐ซ๐ฒ? ๐€๐ฌ๐ค ๐“๐จ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=84893

๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฅ๐ž๐ญ๐ฌ ๐ฒ๐จ๐ฎ ๐ข๐๐ž๐ง๐ญ๐ข๐Ÿ๐ฒ ๐ญ๐ก๐ž ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐Œ๐ข๐œ๐ž ๐Œ๐จ๐๐ž๐ฅ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐›๐ฒ ๐ฆ๐ž๐š๐ง๐ฌ ๐จ๐Ÿ ๐š ๐ซ๐ž๐ ๐ข๐จ๐ง:

North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก -

๐Œ๐ž๐ญ๐š๐ฅ ๐๐จ๐ฐ๐๐ž๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/en/news-release/2022/09/21/2520462/0/en/Metal-Powder-Market-to-Reach-US-12-1-Bn-by-2031-TMR-Study.html

๐๐ซ๐ž๐š๐ญ๐ก๐ข๐ง๐  ๐๐š๐ญ๐ญ๐ž๐ซ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/en/news-release/2022/09/21/2520505/0/en/Breathing-Battery-Market-to-Expand-at-a-CAGR-of-8-5-during-Forecast-Period-TMR-Study.html

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mice Model Technologies Market to Reach US$ 3.2 Billion by 2031: TMR Study here

News-ID: 3342180 • Views: โ€ฆ

More Releases from Transparency Market Research

Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 Billion by 2036 at 5.3% CAGR
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B โ€ฆ
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energyโ€ฆ
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Application | U.S. โ€ข Germany โ€ข China โ€ข India
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati โ€ฆ
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,โ€ฆ
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million to US$ 1,000.2 Million by 2036 at a 17.0% CAGR
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t โ€ฆ
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, andโ€ฆ
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported by Biopharma Growth
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b โ€ฆ
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multipleโ€ฆ

All 5 Releases


More Releases for Mice

Humanized Mice Model Market - From Mice to Medicine: Redefining Research with Im โ€ฆ
Newark, New Castle, USA - new report, titled Humanized Mice Model Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Humanized Mice Model market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Humanized Mice Model market. The report offers an overview ofโ€ฆ
Thailand MICE Forum 2019 Brings World's MICE Leaders Together
Bangkok, 25 September 2019 โ€“ The Thailand Convention and Exhibition Bureau (TCEB) recently successfully staged the Thailand MICE Forum 2019 and for the first time brought together leaders of the world's top MICE organisations under one roof in Bangkok, helping to drive Thailand towards its goal of becoming Asia's top MICE destination. In just its third year, the event attracted leaders of the world's most prominent MICE associations including Mr. Philipโ€ฆ
08-05-2019 | Health & Medicine
MRRSE
Mice Model Market (Type - Transgenic Mice Model, Knockout Mice Model, Carcinogen โ€ฆ
Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nationโ€™s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. Thisโ€ฆ
Global Mice Model Market |mice model, transgenic mice, knockout mice, knockout m โ€ฆ
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled โ€œMice Model Market โ€œ Mouse is a popular model system because it is a mammal with sophisticated genetic tools and significant genetic resources. The prospect of the mice as a model for exploring human pathophysiology and disease progression and for developing drugs isโ€ฆ
Mice Model Market: Mice Model Usage Increases in Scope Through Advanced Models
Biomedical research has taken a front seat in the healthcare and pharmaceutical industries, to a point where a nationโ€™s research and development landscape can be gauged by its level of investment in biomedical research. The past decade has consequently witnessed a staggering rise in biomedical research in most countries, both developed and developing. A significant part of this research investment typically goes into animal models, more specifically, mice models. Thisโ€ฆ
Mice Model Market - Development of mice models of human diseases has progressed โ€ฆ
Mouse is a popular model system because it is a mammal with sophisticated genetic tools and significant genetic resources. The prospect of the mice as a model for exploring human pathophysiology and disease progression and for developing drugs is likely to be further widened by the introduction of new models such as immunedeficient and humanizing mouse in which human tissues and cells or genes are reconstituted. With 99% of theirโ€ฆ